Praxis Precision Medicines (PRAX) Total Liabilities (2019 - 2026)

Praxis Precision Medicines' Total Liabilities history runs 8 years deep, the most recent figure standing at $50.2 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 27.12% year-over-year to $50.2 million; the TTM figure through Mar 2026 stood at $50.2 million (up 27.12% YoY), while the FY2025 annual figure was $59.8 million, up 58.71% from the prior year.
• Total Liabilities for Q1 2026 stood at $50.2 million, down from $59.8 million in the prior quarter.
• The five-year high for Total Liabilities was $59.8 million in Q4 2025, with the low at $18.3 million in Q4 2023.
• The 5-year median for Total Liabilities is $37.7 million (2024), against an average of $36.8 million.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities jumped 252.9% in 2022, then sank 53.16% in 2023.
• Praxis Precision Medicines' Total Liabilities stood at $39.0 million in 2022, then tumbled by 53.16% to $18.3 million in 2023, then soared by 106.03% to $37.7 million in 2024, then jumped by 58.71% to $59.8 million in 2025, then decreased by 15.94% to $50.2 million in 2026.
• Business Quant data shows PRAX's Total Liabilities at $50.2 million in Q1 2026, $59.8 million in Q4 2025, and $52.9 million in Q3 2025.